TRIMETREXATE
Health Topics Pharma News Home
Pharma News Home
FDA Approval Activities for this Drug Neutrexin (trimetrexate glucuronate) Injection, 25 mg, 200 mg, MedImmune Oncology, NDA 20-326/S-011, S-013
Neutrexin (trimetrexate glucuronate) Injection, 25 mg, 200 mg, MedImmune Oncology, NDA 20-326/S-011, S-013
For the latest approval information, please locate this drug using this index.